European Medicines Agency (EMA) to issue its decision on the BioNTech (NASDAQ: BNTX) and Pfizer (NYSE: PFE) vaccines

On December 21, the European Medicines Agency (EMA) expects to issue its decision on the BioNTech and Pfizer vaccines. After emergency approvals from the UK and the US earlier this month, the EU has come under growing pressure to authorize the vaccine. BioNTech and Pfizer had sent a conditional marketing permission proposal for their COVID-19 vaccine to the EMA a fortnight earlier. Currently, this vaccine is one of the most promising ways possible of containing the Corona pandemic.

The German government has previously requested that the form of emergency permission granted by the UK be granted elsewhere, which may negatively affect the population’s readiness to vaccinate. Jens Spahn (German Federal Minister of Health) said on Sunday, at a coronavirus summit between the government and state leaders, that had Germany gone it alone, it would have been “markedly faster” than other countries.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In response to the claimSpahn said that the United Kingdom, Canada, and the United States all approved the vaccine before the European Union, saying that the decision of the European Medicines Agency would mark the first regular vaccine approval for all of the European Union, including the experts from all 27 Member States.

“We maintained that this was going to be done at a European level and not a national level… the ‘us’ is stronger than the I.” He added: “This is good news for the European Union as a whole,” he added.

As it struggles to control the spread of the virus, Germany enters a strict lockdown on Wednesday that will last until at least till 10 January. Until autumn, Germany had significantly lower infection and death rates than most other European countries. However, experts claim that its benefits have been squandered due to the widely held perception that the virus was so well under control that people could relax their behavior.

 The German government hopes that regular rather than emergency approval of vaccines will make manufacturers responsible for vaccine safety and not the government.

Denmark has announced a partial lockdown already in place in major cities has been extended to the nation. Simultaneously, the Swedish prime minister, Stefan Lofven, says she has misread the intensity of the second wave of COVID-19.

In the European Union, Sweden focuses on social responsibility rather than lockdowns to contain the epidemic. Still, after seeing a dramatic spike in new cases that overwhelmed the healthcare system, gatherings of more than eight people and alcohol purchases after 10 pm have been prohibited.

A small increase in the number of new cases in Spain prompted the national government to call on people to exercise more caution. Over the last few weeks, Spain’s infection levels have fallen from a daily high of over 20,000 in October to fewer than 10,000. The latest weekend figures showed the number of cases per 100,000 people rose from 190 on Friday to 194 on Monday.

Most Popular